A1BG, a secreted glycoprotein often overexpressed in cancer,[17, 28] has been linked to poor outcomes in cholangiocarcinoma;[29] however, its role in osteosarcoma chemoresistance remains unknown. This evidence concerns the gene A1BG and cholangiocarcinoma.